Beta Bionics, Inc. (BBNX)
(Delayed Data from NSDQ)
$16.40 USD
-0.39 (-2.32%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $16.39 -0.01 (-0.06%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth B Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Beta Bionics, Inc. has a market cap of $729.86M, which represents its share price of $16.79 multiplied by its outstanding shares number of 43.47M. As a small-cap company, BBNX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
BBNX 16.40 -0.39(-2.32%)
Will BBNX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BBNX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BBNX
BBNX Stock May Gain From Abbott Deal to Advance iLet Integration
BBNX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for BBNX
Beta Bionics, Inc. 2025 Q2 - Results - Earnings Call Presentation
Beta Bionics, Inc. (BBNX) Q2 2025 Earnings Call Transcript
Beta Bionics (BBNX) Receives Target Price Upgrade from Truist Securities | BBNX Stock News
BBNX Analyst Rating Update: Price Target Raised by Baird | BBNX Stock News
Beta Bionics (BBNX) Price Target Raised Amid Strong Q2 Performance